福斯科林市場規模、佔有率、成長分析（按實力、按應用、按最終用戶、按地區）—2025 年至 2032 年產業預測

2023 年，福斯可林市場規模價值為 5.113 億美元，預計將從 2024 年的 5.6396 億美元擴大到 2032 年的 12.3554 億美元，預測期內（2025-2032 年）的複合年成長率為 10.3%。

福斯可林因其在提高環磷酸腺苷水平方面的作用而聞名，環磷酸腺苷可以調節新陳代謝和炎症，並且已成為一種流行的減肥補充劑和治療氣喘、濕疹和乾癬的藥物。它用於阿育吠陀醫學和對抗療法，但其有效性和安全性仍需進一步研究。隨著健康意識的增強，全球對草藥產品的需求不斷增加，這反映了膳食補充劑、食品、飲料和化妝品的萃取物純度水平範圍不斷擴大。在北美，尤其是美國，由於肥胖率上升和對天然替代品的偏好，福斯可林佔據了市場佔有率。在亞太地區，印度憑藉其在傳統草藥方面的根基佔據市場領先地位。研究表明，福斯可林可能有助於改善身體組成和氣喘，其市場影響有望成長。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究
• 技術進步

福斯可林市場規模（依濃度及複合年成長率） （2025-2032）

• 市場概覽
• 低濃度（10%）
• 中等濃度（20%-40%）
• 高濃度（95%）

福斯可林市場規模（依應用）及複合年成長率（2025-2032）

• 市場概覽
• 過敏治療
• 體重管理
• 呼吸問題
• 心血管疾病
• 青光眼
• 甲狀腺機能低下症
• 乾癬
• 其他

福斯可林市場規模（依最終用戶分類）及複合年成長率（2025-2032）

• 市場概覽
• 營養補充品
• 製藥
• 營養補充品
• 其他

福斯可林市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Alchem International Ltd.（India）
• Nutra Green Biotechnology Co., Ltd.（China）
• Shaanxi Jiahe Phytochem Co., Ltd.（China）
• Glentham Life Sciences（United Kingdom）
• Flavour Trove（India）
• Cymbio Pharma Pvt. Ltd.（India）
• Alpspure Lifesciences Pvt. Ltd.（India）
• Bioprex Labs（India）
• Deccan Nutraceuticals Pvt. Ltd.（India）
• Ennature Biopharma（India）
• Sunpure Extracts Pvt. Ltd.（India）
• Sabinsa Corporation（United States）
• Indena SpA（Italy）
• ChromaDex Corp.（United States）
• Herbal Nutrition LLC（United States）
• Himalaya Wellness（India）
• Life Extension（United States）
• Nature's Way Products, LLC（United States）
• Swanson Health Products, Inc.（United States）
• NOW Foods（United States）

結論和建議

Forskolin Market size was valued at USD 511.3 million in 2023 and is poised to grow from USD 563.96 million in 2024 to USD 1235.54 million by 2032, growing at a CAGR of 10.3% during the forecast period (2025-2032).

Forskolin, known for its role in enhancing cyclic AMP levels-which regulates metabolism and inflammation-has gained traction as a weight loss supplement and treatment for asthma, eczema, and psoriasis. Despite the need for more research on its efficacy and safety, its use spans both Ayurvedic and allopathic medicine. Variations in extract purity cater to dietary supplements, food and beverages, and cosmetics, reflecting a growing global demand for herbal products as health concerns escalate. In North America, particularly the U.S., forskolin leads with over 90% market share, driven by rising obesity rates and the preference for natural alternatives. In the APAC region, India tops the market, supported by its traditional medicinal roots. As studies suggest forskolin's potential in improving body composition and aiding asthma, its market presence is poised for growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Forskolin market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Forskolin Market Segments Analysis

Global Forskolin Market is segmented by Concentration, Application, End-User and region. Based on Concentration, the market is segmented into Low Concentration (10%), Medium Concentration (20%-40%) and High Concentration (95%). Based on Application, the market is segmented into Allergy Treatment, Weight Management, Respiratory Problems, Cardiovascular Disorders, Glaucoma, Hypothyroidism, Psoriasis and Others. Based on End-User, the market is segmented into Nutraceuticals, Pharmaceuticals, Dietary Supplements and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Forskolin Market

A key factor propelling the Forskolin market is the surging demand for natural health supplements. Forskolin, extracted from the root of the Coleus forskohlii plant, has a long history in traditional medicine for treating various health issues. As consumers become more aware of the benefits associated with natural products and express growing concerns about the adverse effects of synthetic pharmaceuticals, the appeal of Forskolin supplements is on the rise. Additionally, the increasing incidence of chronic illnesses like obesity and cardiovascular diseases is further bolstering the market, as Forskolin is widely regarded as a safe and effective option for managing such health challenges.

Restraints in the Forskolin Market

A significant challenge facing the Forskolin market is the absence of regulation and standardization in the manufacturing and distribution processes of Forskolin products. As the demand for natural health supplements has surged, a wide array of Forskolin products has flooded the market, many of which may not adhere to established quality and safety standards. This situation poses a risk for consumers who might end up purchasing products that are not only ineffective but could also be detrimental to their health. Additionally, the lack of regulation leads to inconsistencies in the potency and purity of these products, resulting in varying therapeutic benefits, which undermines consumer trust and market stability.

Market Trends of the Forskolin Market

The forskolin market is experiencing a notable trend driven by a growing preference for natural and herbal remedies among health-conscious consumers. As more individuals seek alternatives to synthetic chemicals, forskolin-derived from the Coleus forskohlii plant-has gained traction for its potential health benefits, including weight management and metabolic improvement. This increasing awareness is further fueled by the rising prevalence of lifestyle-related conditions such as obesity and diabetes, prompting consumers to explore natural solutions. Additionally, the market is becoming increasingly competitive, with new entrants pushing innovation and the development of diverse, innovative forskolin products, thereby amplifying the market's growth trajectory.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Forskolin Market Size by Concentration & CAGR (2025-2032)

• Market Overview
• Low Concentration (10%)
• Medium Concentration (20%-40%)
• High Concentration (95%)

Global Forskolin Market Size by Application & CAGR (2025-2032)

• Market Overview
• Allergy Treatment
• Weight Management
• Respiratory Problems
• Cardiovascular Disorders
• Glaucoma
• Hypothyroidism
• Psoriasis
• Others

Global Forskolin Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Nutraceuticals
• Pharmaceuticals
• Dietary Supplements
• Others

Global Forskolin Market Size & CAGR (2025-2032)

• North America (Concentration, Application, End-User)
  • US
  • Canada
• Europe (Concentration, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Concentration, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Concentration, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Concentration, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Alchem International Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nutra Green Biotechnology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shaanxi Jiahe Phytochem Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glentham Life Sciences (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Flavour Trove (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cymbio Pharma Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alpspure Lifesciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioprex Labs (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Deccan Nutraceuticals Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ennature Biopharma (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sunpure Extracts Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sabinsa Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indena S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ChromaDex Corp. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Herbal Nutrition LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Himalaya Wellness (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Life Extension (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nature's Way Products, LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Swanson Health Products, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NOW Foods (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations